Key takeaways Semaglutide was first approved by the FDA to treat type 2 diabetes under the brand name Ozempic in 2017
Metformin is a well-known pill that helps manage type 2 diabetes
Understanding the regulatory differences between compounded and FDA-approved medications and having the opportunity to discuss both options with a provider allows for a more informed treatment decision
Jin Chai, Department of Gastroenterology, Institute of Digestive Diseases of PLA, Cholestatic Liver Diseases Center and Center for Metabolic Dysfunction-Associated Fatty Liver Disease, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing, Chongqing, China
Scope of the Report Key Target Audience Investors and Venture Capitalist Firms Government and Regulatory Bodies (e.g., Ministry of Health and Welfare, Korea Food and Drug Administration) Pharmaceutical Manufacturers Healthcare Providers and Hospitals Insurance Companies Pharmacy Chains and Retail Pharmacies Biotechnology Firms Health Technology Assessment Agencies Players Mentioned in the Report: Novo Nordisk A/S Eli Lilly and Company Sanofi S.A
